B. Riley sees mixed Q4 results but gains aftermarket interest. Despite mild improvements, my long-term view on RILY stock is negative. Read an analysis here.

Equities researchers at B. Riley lowered their Q1 2025 earnings per share (EPS) estimates for shares of Abacus Life in a ...

Equities research analysts at B. Riley dropped their Q2 2025 earnings per share (EPS) estimates for Trevi Therapeutics in a ...

B. Riley Financial, Inc.’s RILY share price has dipped by 10.10%, which has investors questioning if this is right time to buy.

Fintel reports that on March 19, 2025, B. Riley Securities downgraded their outlook for Quanta Services (NYSE:PWR) from Buy ...

B. Riley Securities, the investment banking group, has merged with Cascadia Investments Inc., a shell entity. As a result, ...

B. Riley analyst Nick Giles initiated coverage of United States Antimony (UAMY) with a Buy rating and $3 price target U.S. Antimony could more ...

Pre-earnings options volume in B Riley Financial is normal with puts leading calls 8:5. Implied volatility suggests the market is anticipating ...

B. Riley Financial Inc. missed the deadline for filing its annual report for a third year in a row, delaying its to return to a normal schedule as the firm deals with the aftermath of soured ...

Fintel reports that on March 21, 2025, B. Riley Securities initiated coverage of United States Antimony (NYSEAM:UAMY) with a Buy recommendation. Analyst Price Forecast Suggests 49.58% Upside As of ...

Bryant R. Riley has served as chairman and co-chief executive officer of B. Riley Financial since June 2014 and July 2018 ...

Shares of B. Riley Financial were recently down 2.7%, to $4.34. The stock has fallen about 6% this year and 78% over the past 52 weeks.